| __timestamp | Rhythm Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 2917513 |
| Thursday, January 1, 2015 | 3425000 | 7878291 |
| Friday, January 1, 2016 | 6311000 | 8366794 |
| Sunday, January 1, 2017 | 9518000 | 6610381 |
| Monday, January 1, 2018 | 28080000 | 6556000 |
| Tuesday, January 1, 2019 | 36550000 | 6930000 |
| Wednesday, January 1, 2020 | 46125000 | 8758000 |
| Friday, January 1, 2021 | 68486000 | 10806000 |
| Saturday, January 1, 2022 | 92032000 | 9844000 |
| Sunday, January 1, 2023 | 117532000 | 13481000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. Rhythm Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Rhythm Pharmaceuticals experienced a staggering increase in SG&A expenses, growing nearly 9,600% from 1.2 million to 117.5 million. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Soleno Therapeutics maintained a more stable trajectory, with expenses rising by approximately 360% from 2.9 million to 13.5 million.
These trends highlight the differing strategies of these companies in navigating the biotech landscape. While Rhythm Pharmaceuticals focuses on rapid growth, Soleno Therapeutics opts for a more measured approach, balancing cost management with strategic investments.
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared